Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie puts up $105M for Tizona's preclinical I/O drug
BioPharma Dive
Sat, 01/5/19 - 12:04 am
Tags:
AbbVie, Tizona Therapeutics, TTX-030, immuno-oncology
AbbVie Strikes Deal With Lupin for Blood Cancer Program
BioSpace
Wed, 01/2/19 - 06:36 pm
Tags:
AbbVie, Lupin, India, MALT1 inhibitors
The Most Promising Biotech Names Heading Into 2019
Investopedia
Mon, 12/31/18 - 12:18 pm
Tags:
biotech, AbbVie, Novavax, Amarin, TG Therapeutics
The biotechs promising to slow down aging
GoinPharma
Mon, 12/31/18 - 12:00 pm
Tags:
Unity Biotechnology, Life Length, AbbVie, Calico, aging
AbbVie gets rights to Lupin's MALT1 program
BioCentury
Wed, 12/26/18 - 03:44 pm
Tags:
AbbVie, Lupin, MALT1 inhibitors
AbbVie streamlines management team to 4 executives under CEO Gonzalez
Fierce Pharma
Mon, 12/17/18 - 08:16 pm
Tags:
AbbVie, reorganization, Richard Gonzalez, Pharma CEOs
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
Reuters
Mon, 12/17/18 - 08:15 pm
Tags:
Eli Lilly, psoriatic arthritis, Taltz, AbbVie, Humira, clinical trials
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
Mon, 12/10/18 - 07:07 pm
Tags:
clinical trials, Multiple Myeloma, adaptive trial design, AbbVie, Celgene, Eli Lilly, Genentech, Janssen, Takeda
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
Thu, 12/6/18 - 07:01 pm
Tags:
AbbVie, Imbruvica, CLL, JNJ, ASH 2018
AbbVie suffers fresh setback with lung cancer drug Rova-T
Pharmaforum
Thu, 12/6/18 - 12:33 pm
Tags:
AbbVie, Rova-T, lung cancer, advanced SCLC
AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023
Fierce Pharma
Fri, 11/30/18 - 12:36 pm
Tags:
AbbVie, biosimilars, Pfizer, Humira, patents
AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena
Fierce Pharma
Mon, 11/26/18 - 12:35 pm
Tags:
AbbVie, Venclexta, Roche, AML
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
CP Wire
Mon, 11/26/18 - 10:21 am
Tags:
Rheostat Therapeutics, Merck, AbbVie, Amgen
Why Abbvie Is Down 5% in 2018 So Far
Motley Fool
Sat, 11/17/18 - 12:44 pm
Tags:
AbbVie, Imbruvica, Humira, Orilissa
7 drugs that raised eyebrows in Q3
Biopharma Dive
Thu, 11/15/18 - 11:50 pm
Tags:
Sanofi, Dupixent, Roche, Herceptin, AbbVie, Humira, Regeneron, Repatha, Clovis Oncology, Rubraca, GSK, Shingrix, Eli Lilly, Trulicity
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
Fierce Pharma
Thu, 11/15/18 - 11:39 pm
Tags:
AbbVie, Orilissa, FDA, uterine fibroids, Neurocrine
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
Endpoints
Thu, 11/15/18 - 10:48 am
Tags:
targeted protein degradation, AbbVie, Mission Therapeutics, Alzheimer's disease, Parkinson's Disease
AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
Fierce Pharma
Tue, 11/13/18 - 10:24 pm
Tags:
AbbVie, hepatitis C, Mavyret, Medicines Patent Pool
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
RAPS.org
Fri, 11/9/18 - 11:34 am
Tags:
Boehringer Ingelheim, AbbVie, Humira, patents, biosimilars
AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point
Endpoints
Thu, 11/8/18 - 12:09 pm
Tags:
AbbVie, San Francisco, Oyster Point, biotech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.